venBio Partners LLC
Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| ALUMIS INC | 0 | 4,528,408 | +4,528,408 | 0 | 99,760,828 | 35.56% | +99,760,828 |
| ALX ONCOLOGY HLDGS INC | 0 | 12,884,638 | +12,884,638 | 0 | 25,833,699 | 9.21% | +25,833,699 |
| LYELL IMMUNOPHARMA INC | 0 | 337,697 | +337,697 | 0 | 6,774,202 | 2.41% | +6,774,202 |
| PHARVARIS N V | 0 | 4,639,304 | +4,639,304 | 0 | 131,060,338 | 46.71% | +131,060,338 |
| ARTIVA BIOTHERAPEUTICS INC | 0 | 531,337 | +531,337 | 0 | 3,421,810 | 1.22% | +3,421,810 |
| HARMONY BIOSCIENCES HLDGS IN(HRMY) | 0 | 489,194 | +489,194 | 0 | 13,702,324 | 4.88% | +13,702,324 |
| LYELL IMMUNOPHARMA INC | 0 | 0 | 0 | 0 | 0 | — | 0 |